We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.36%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
KC
451
Kingfisher Capital
North Carolina
$1.79M -$95.5K -461 -5%
JMPWA
452
JP Morgan Private Wealth Advisors
California
$1.76M -$110K -533 -6%
B
453
Barings
North Carolina
$1.72M -$331K -1,600 -17%
CTA
454
Chesley Taft & Associates
Illinois
$1.71M +$10.4K +50 +0.7%
CCA
455
Catalyst Capital Advisors
New York
$1.69M
ACM
456
Atika Capital Management
New York
$1.67M +$1.55M +7,500 New
CB
457
Chemical Bank
Michigan
$1.67M +$115K +557 +8%
AIM
458
abrdn Investment Management
United Kingdom
$1.65M +$1.53M +7,408 New
DC
459
Deere & Company
Illinois
$1.63M -$26.7K -129 -2%
EHWM
460
Eads & Heald Wealth Management
Georgia
$1.6M -$47.2K -228 -3%
LBG
461
Lloyds Banking Group
United Kingdom
$1.6M -$11.3M -54,777 -88%
TAM
462
Tealwood Asset Management
Minnesota
$1.58M -$66.3K -320 -4%
FNBT
463
FineMark National Bank & Trust
Florida
$1.57M +$214K +1,034 +17%
SOAMC
464
Spirit of America Management Corp
New York
$1.56M -$311K -1,500 -18%
PCM
465
Prelude Capital Management
New York
$1.54M +$20.7K +100 +1%
ID
466
Integral Derivatives
New York
$1.44M -$644K -3,109 -33%
NB
467
Norinchukin Bank
Japan
$1.44M -$159K -769 -11%
KeyBank National Association
468
KeyBank National Association
Ohio
$1.42M +$307K +1,482 +30%
BF
469
BOK Financial
Oklahoma
$1.38M +$4.97K +24 +0.4%
FPC
470
Falcon Point Capital
California
$1.36M +$335K +1,616 +36%
PPCM
471
Pillar Pacific Capital Management
California
$1.36M +$118K +570 +10%
KRSITF
472
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$1.35M +$7.66K +37 +0.6%
NCA
473
NCM Capital Advisers
North Carolina
$1.33M +$186K +900 +18%
MERSOM
474
Municipal Employees' Retirement System of Michigan
Michigan
$1.32M
FQ
475
First Quadrant
California
$1.31M +$699K +3,376 +135%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.